125 related articles for article (PubMed ID: 2458308)
21. Cell-mediated hepatic injury in alcoholic liver disease. Veterans Affairs Cooperative Study Group 275.
Chedid A; Mendenhall CL; Moritz TE; French SW; Chen TS; Morgan TR; Roselle GA; Nemchausky BA; Tamburro CH; Schiff ER
Gastroenterology; 1993 Jul; 105(1):254-66. PubMed ID: 8514042
[TBL] [Abstract][Full Text] [Related]
22. Is apoptosis involved in alcoholic hepatitis?
Kawahara H; Matsuda Y; Takase S
Alcohol Alcohol Suppl; 1994; 29(1):113-8. PubMed ID: 9063809
[TBL] [Abstract][Full Text] [Related]
23. Histologic features and bile duct lesions in the alcoholic.
Yamada S; Takezawa J; Takagi H; Abe T; Sakurai S; Kobayashi S
Jpn J Med; 1985 Aug; 24(3):223-30. PubMed ID: 4068358
[TBL] [Abstract][Full Text] [Related]
24. HCV infection, hepatic HLA display and composition of the mononuclear cell inflammatory infiltrate in chronic alcoholic liver disease.
Freni MA; Ajello A; Resta ML; Gaeta GB; Spadaro A; Fava A; Calapristi I; Alessi N; Ferraù O
Eur J Clin Invest; 1991 Dec; 21(6):586-91. PubMed ID: 1723384
[TBL] [Abstract][Full Text] [Related]
25. Cytokeratin 7 staining of hepatocytes predicts progression to more severe fibrosis in alcohol-fed baboons.
Ren C; Paronetto F; Mak KM; Leo MA; Lieber CS
J Hepatol; 2003 Jun; 38(6):770-5. PubMed ID: 12763370
[TBL] [Abstract][Full Text] [Related]
26. Computerized morphometry of the cirrhotic liver: comparative analysis in primary biliary cirrhosis, alcoholic cirrhosis, and posthepatitic cirrhosis.
Vertemati M; Minola E; Goffredi M; Sabatella G; Gambacorta M; Vizzotto L
Microsc Res Tech; 2004 Oct; 65(3):113-21. PubMed ID: 15605407
[TBL] [Abstract][Full Text] [Related]
27. Serum markers of hepatocyte death and apoptosis are non invasive biomarkers of severe fibrosis in patients with alcoholic liver disease.
Lavallard VJ; Bonnafous S; Patouraux S; Saint-Paul MC; Rousseau D; Anty R; Le Marchand-Brustel Y; Tran A; Gual P
PLoS One; 2011 Mar; 6(3):e17599. PubMed ID: 21445263
[TBL] [Abstract][Full Text] [Related]
28. Infiltrating polymorphonuclear leukocytes and apoptotic bodies derived from hepatocytes but not from ballooning hepatocytes containing Mallory bodies show nuclear DNA fragmentation in alcoholic hepatitis.
Takahashi T; So-Wan T; Kamimura T; Asakura H
Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):68S-73S. PubMed ID: 10803784
[TBL] [Abstract][Full Text] [Related]
29. Increased expression of proliferating cell nuclear antigen in liver allograft rejection.
Ray MB; Schroeder T; Michaels SE; Hanto DW
Liver Transpl Surg; 1996 Sep; 2(5):337-42. PubMed ID: 9346673
[TBL] [Abstract][Full Text] [Related]
30. The Mallory body: theories on development and pathological significance (Part 2 of a literature survey).
Jensen K; Gluud C
Hepatology; 1994 Nov; 20(5):1330-42. PubMed ID: 7927269
[TBL] [Abstract][Full Text] [Related]
31. Use of a specific monoclonal antibody to detect Mallory bodies in liver disease.
Leevy CB; Sameshima Y; Yoshioka K; Leevy CM; Kanagasundaram N; Unoura M
J Assoc Acad Minor Phys; 1990; 1(2):24-5, 28-30. PubMed ID: 2135694
[TBL] [Abstract][Full Text] [Related]
32. Cytokeratin immunostaining for detection of biliary epithelium: its use in counting bile ducts in cases of liver allograft rejection.
Harrison RF; Patsiaoura K; Hubscher SG
J Clin Pathol; 1994 Apr; 47(4):303-8. PubMed ID: 7517955
[TBL] [Abstract][Full Text] [Related]
33. TUNEL-positive hepatocytes in alcoholic liver disease. A retrospective biopsy study using DNA nick end-labelling.
Zhao M; Laissue JA; Zimmermann A
Virchows Arch; 1997 Nov; 431(5):337-44. PubMed ID: 9463575
[TBL] [Abstract][Full Text] [Related]
34. Pathology of cytoskeleton of liver cells: demonstration of mallory bodies (alcoholic hyalin) in murine and human hepatocytes by immunofluorescence microscopy using antibodies to cytokeratin polypeptides from hepatocytes.
Denk H; Franke WW; Dragosics B; Zeiler I
Hepatology; 1981; 1(1):9-20. PubMed ID: 6169613
[No Abstract] [Full Text] [Related]
35. Cytokeratin inclusions in alcoholic liver disease and their relation to the amount of alcohol intake.
Savolainen VT; Lalu K; Penttilä A; Virtanen I; Karhunen PJ
Liver; 1994 Dec; 14(6):281-7. PubMed ID: 7533231
[TBL] [Abstract][Full Text] [Related]
36. Portal tract eosinophils and hepatocyte cytokeratin 7 immunoreactivity helps distinguish early-stage, mildly active primary biliary cirrhosis and autoimmune hepatitis.
Goldstein NS; Soman A; Gordon SC
Am J Clin Pathol; 2001 Dec; 116(6):846-53. PubMed ID: 11764073
[TBL] [Abstract][Full Text] [Related]
37. Expression of cytokeratins in normal and diseased livers and in primary liver carcinomas.
Lai YS; Thung SN; Gerber MA; Chen ML; Schaffner F
Arch Pathol Lab Med; 1989 Feb; 113(2):134-8. PubMed ID: 2464975
[TBL] [Abstract][Full Text] [Related]
38. Pathologic changes in the cytokeratin pericanalicular sheath in experimental cholestasis and alcoholic fatty liver.
Ohta M; Marceau N; French SW
Lab Invest; 1988 Jul; 59(1):60-74. PubMed ID: 2455832
[TBL] [Abstract][Full Text] [Related]
39. [Alcoholic liver disease in Venezuela. Clinical hepato-functional and histopathologic course].
Arocha R; Pérez Machado L; Hamana N
G E N; 1990; 44(1):15-20. PubMed ID: 2152250
[TBL] [Abstract][Full Text] [Related]
40. Cytokeratin immunohistochemical examination of liver biopsies in infants with Alagille syndrome and biliary atresia.
Treem WR; Krzymowski GA; Cartun RW; Pedersen CA; Hyams JS; Berman M
J Pediatr Gastroenterol Nutr; 1992 Jul; 15(1):73-80. PubMed ID: 1383485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
